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Heterozygous mutations in the gene for the Kit 
transmembrane receptor have been identified re-
cently in human piebaldism and mouse "dominant 
spotting." Interestingly, all of the 14 known missense 
lDutations that cause depigmentation in these species 
Dlap to the tyrosine kinase domain of the receptor, 
whereas none have involved the extracellular ligand-
binding domain. In an attempt to detect these un-
COJn.mon mutations, we screened the nine exons 
encoding the extracellular portion of Kit for single-
strand conformation polymorphisms (SSCP) in eight 
piebald subjects previously reported to be negative 
for kinase mutations. Four of these eight kindreds 
proved to carry novel mutations. The first mutation, 
found in two apparently unrelated pro bands with 
lDild piebaldism and English ancestry, substitutes an 
arginine for a highly conserved cysteine at codon 136. 
This substitution disrupts a putative disulfide bond 
required for formation of the second Ig-like (D2) loop 
H U111an piebaldism is an autosomal dominant disor-der in melanocy te development characterized b y a white hair forelock, areas of hypo pigme ntation on the antel"ior trunk and extremities, and the abse nce of other manifestations (Ortonne, 1988). Based on 
the similarity of the human phenotype to mouse " dominant spot-
ting," which results from mutations in the c-kit gene (Chabot et ai, 
1988; Geissler et ai, 1988), we and others recently identified 
heterozygous mutations of the human c-kit gene in kindreds with 
piebaldism (Fle ischman e/ ai, 1991; Giebel and Spritz, 1991) . 
In contrast to the findings for other transmembrane tyrosine 
kinases such as the in sulin receptor (Flier, 1992), aJl of the 14 
independently arising missense mutations that result in depigmen-
tatiOl)' have mapped to the intracellular domains that catalyze 
tyrosine phosphorylation (Nocka c/ ai, 1990; R eith e( ai, 1990; Tan 
et af, 1990; Giebel and Spritz, 1991; Fleischman, 1992; Larue e( ai, 
1992; Spritz et ai, 1992a, 1992b, 1993; Tsujimura e( ai, 1993; Ezoe 
e/ ai, 1995). The relative rarity of mutations in tlle extracellular 
domains suggests that the d efects resulting £i'om amino acid substi-
tutions in the ligand-binding region are generally too mild to cause 
depigmentation . On the other hand, the iden tifi cation ofmutatiol1s 
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of the Kit ligand-binding domain. The second muta-
tion, detected in a piebald kindred characterized by 
unusually limited depigmentation, substitutes a 
threonine for an alanine at codon 178, a site just 
proximal to conserved cysteines at co dons 183 and 
186. The third mutation, occnrring in a kindred with 
more extensive depigmentation, is a novel four-base 
insertion in exon 2 that results in a proximal frame-
shift and premature termination. The data strongly 
suggest that piebaldism can result from missense 
mutations in the Kit ligand-binding domain, al-
though the resulting phenotype may be milder than 
that observed for null or kinase mutations. The ap-
parent clustering of these uncommon mutations at or 
near the conserved cysteines for the D2 Ig-like loop 
further suggests a critical role for this region in Kit 
receptor function. Key words: pigmetltation disOl'ders/ 
melatlocytes/tyl'osine kitlase. ] bwest DeJ?l/atol 107:703-
706, 1996 
in the extracellular portion of tlle receptor may reveal moieties that 
are particularly important for ligand binding or other aspects of 
receptor function. 
In this regard. we now report three novel mutations in four 
subjects with pie baldism, including two missense mutations that 
map to Kit exon 3, a sequence that encodes the second of five 
Ig-like loops that form the extracellular portion of the receptor. 
MATER.IALS AND METHODS 
Subjects The piebald subjects, from apparently unrelated kindreds , have 
been described previously (Fleischman ct aI, 1991; Fleischman, 1992). 
Probands 1 and 2 were previously designated as subjects E and F (Fleisch-
man ct ai , 1991) . These subjects are apparently unrelated Caucasian males of 
English ancestry with a f.1mily history of multiple generations of piebald 
individuals. Both kindreds display mild piebaldism with small areas of 
spotting on the ventral abdomen. with or without a small whitc hair 
forelock. For example, proband 2 exhibits only a small arca ofleukoderma 
in the midabdomen bm no white hair forelock, altllOugh the mother also has 
a typical small white fore lock. Proband 3 was previously designated as 
subject I (Flcisclll1lan, 1992). T his proband and one similarly affected sibling 
have unusually mild depigmentation, consisting only of a small wh.ite hair 
forelock at birth that gradually became unapparent after the first few years 
oflife. Proband 4 was previously designated as subject G (Fleischman el ai, 
1991) and has a prominent white forelock and extensive areas of leuko-
derma 011 the abdomen. arms, and legs. 
Single-Stranded Conformation Polymorph isms (SSCP) For tl,e de-
tection ofSSCP, we perfon1l cd polymerase chain rcaction (PCR) Witll 1 f.l.g 
of genomic DNA, 50 f.l.M each dNTP, 0.4 f.l.M each oligonucleotide primer. 
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10 mM Tris HCI (pH 8.3), 50 mM KCI , 1.5 mM MgCI2 , 0 .25 U Them.lIs 
aqll a'i",s DNA polymerase (Perkin-Elmer/Cetus, Norwalk, CT), and to 
ILCi of[a-3 2P]dCTP (3000 Ci per mmol, 10 mCi per ml) in a final volume 
of 25 ILl. The sequences of the primer pairs for PCR were: exon 2, 
5' -TACAGGATCCTACTCAACACGATTCTGTTT-3 ' /5' -CACTGAAT-
TCCTGCAGAAAGCCAAGCATTT-3'; and exon 3, 5'-TACTGATTTG-
GATATGCTTC-3'/5'-CTCCAGAGGCAGATAAGAAA-3'. 
PCR was performed for 40 cycles at a denaturation temperature of 94°C 
for 1 min, primer annealing at 55°C for 1 min, and extension at 72°C for 2 
min. The PCR product (1.5 ILl) was added to 20 ILl offormamide dye (98% 
formamide120 mM ethylenediamine tetraacetic acid/0.05% bromophenol 
blue) , and immediately before electrophoresis, the samples were heated in 
a boiling water bath for 6 min. Aliquots (2 ILl) of each denatured sample 
were loaded onto a 38 cm X 20 cm X 0.4 mm 5.5% polyacrylamide gel 
(19:1 ratio of acrylamide to bis-acrylamide) with 10% glycerol and 2 X TBE 
buffer (50 mM Tris, pH 8.0/50 mM boric acid/l mM ethylenediamine 
tetraacetic acid). Electrophoresis was performed at 300 V at room temper-
ature for 16-24 h. After electrophoresis, the gels were transferred to 
Whatrnan 3M paper (Maidstone, U .K.) and dried on a vacuum slab gel 
dryer for 2 h at 80°C. Autoradiography with Kodak X-Omat film (Roch-
ester, NY) at room temperature without intensifying screens allowed 
detection of PCR products in 4-12 h of exposure. 
DNA Cloning and Sequencing PCR was carried out as described 
previously, with the modification that the total volume was 100 ILl and the 
concentration of dNTPs was 200 ILM, with no radioactive label added. To 
confirm the absence of contamination in negative control samples and to 
ensure that the PCR product was a single band of the appropriate size, we 
visualized 1 ILl of the PCR. product after electrophoresis in a 3% NuSieve 
(FMC Bioprodllcts, Rockland, ME)-I% agarase minigel. To prepare the 
exon-3 DNA for ligation , 1 ILl of T4 DNA polymerase was added to the 
PCR. reaction mixtures and incubated for an additional 20 min at 37°C . The 
reaction product was then purified by electrophores.is overnight at 300 V on 
10% polyacrylamide gels, visualized by ethidium bromide staining, excised, 
and cloned into M13 mp18 by ligation at the BamHl and EcoRI sites with 
T4 DNA ligase. M13 single-stranded DNA was sequenced with modified 
T7 DNA polymerase (Sequenase, Version 2.0; United States Biochemical, 
C leveland, OH) using [a-35S1dATP (1000 Ci/mmol) according to the 
protocol supplied by the manufacturer. Exon-2 fragments were cloned into 
the PCR II vector by TA cloning according to the manufacturer's protocol 
(Invitrogen, San Diego, CAl and were sequ'enced by automated bidirec-
tional· dye terminator sequencing. 
Restriction Digest and Analysis Kit exon-3 PCR fragments were 
independently reamplified from the piebald subjects with mutations in exon 
3 and from a norma'! control, cleaved by repetitive incubation with either 
NspBIl for the mutation at codon 136 or HiraI for the mutation at codon 
1.78, and analyzed by a 3% NuSieve-1 % agarose minigel. Kit exon-2 PCR. 
fragments were independently rcamplified from piebald subject 4 and a 
normal control, cleaved by incubation with Mspl, and analyzed on a 5% 
NuSieve agarose minigel. 
RESULTS 
Probands 1 and 2 Are Heterozygous for a Missense Substi-
tution at Codon 136 Genomic PCR was u sed to amplify c-kit 
exons from nine piebald probands, one of whom has been reported 
previously to have a d e letion (Fleischman et ai, 1991). SSCP 
analysis of the amplified DNA fragments corresponding to exons 
1-9 demonstrated a variant SSCP pattern in exon 3 for probands 1 
and 2 (Fig 1. laues 2,3). To determine the basis for the altered 
SSCP, we independently reamplified the PCR products and cloned 
them into M13. Sequencing of the clones corresponding to lanes 2 
and 3 demonstrated a h eterozygous transition in codon 136 (TGT 
~ CGT), which sub stitutes arginin e for cysteine (Fig 2). Because 
this substitution e liminates a unique NspBII restriction site in the 
DNA sequence of exon 3, the presence of the heterozygous 
mutation was confirmed by digestion of independently amplifIed 
PCR products from both probands and normal controls with 
NspBII (not shown) . 
Proband 3 Is Heterozygous for a Missense Substitution at 
Codon 178 SSCP analysis of the amplified DNA fragments 
corresponding to exon 3 also demonstrated a subtle variant SSCP 
pattern for proband 3 (Fig 1. lalle 4). To determine the basis for 
this variant, w e independently reamplified the PCR product and 
cloned it into M13 mp18. Sequencing of the clone (Fig 1. lalle 4) 
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Figure 1. SSCP of c-kit exon 3 amplified from the DNA of piebald 
subjects. DNA was amplified by PCR., denatured, and subjected to 
polyacrylamide gel electrophoresis under neutral conditions. No variants 
were detected in lalle 1, a normal contro l, and lalles 5-9. Lat.es 2,3 (probands 
1 and 2) show a variant pattern with two additional bands indicated in lalle 
2 (an·olll). Lalle 4 (proband 3) also shows a distinct variant pattern with an 
additional faint band at the top of the gel and a broader band in the middle 
of the gel. The major band at the bottom in all samples corresponds to the 
native double-stranded PCR product. 
demonstrated a heterozygous transltton in codon 178 (GCC ~ 
ACC), which substitutes a threonine for alanine (Fig 3). Because 
this mutation efuninates a unique HILaI restriction site in exon 3, the 
presence of the h eterozygous mutation was confirmed by digestion 
of an independently amplified PCR product from proband 3 with 
HhaI. In contrast, the eight other piebald subjects and 12 unrelated 
normal controls exhibited the normal digestion pattern (not 
shown) . 
A. Normal B. Mutant 
GATe 
---~ - -:,. 
-- -Am=: = 
---- -:::- -
GATe 
- - -
- -::::::;:: .... -
-G'Z-E: 
Val Arg Arg Pro Leu 
Mutant 5'-GTC CGC CGT CCT CTC 
3'-CAG GCG GCA GGA GAG 
t 
Normal 5'-GTC CGC IGT CCT CTC 
3'-CAG GCG ACA GGA GAG 
Val Arg Cys Pro Leu 
Figure 2. Partial nucleotide sequence analysis of c-kit exon-3 
cDNA from proband 2. Exon 3 from proband 2 (Fig 1. lalle 3) was 
amplified by PCR. and cloned into M13. The nucleotide sequences were 
determined for eight clones obtained ITom two independent PCR. reactions. 
Shown are portions of the sequencing ladder spanning the mutation at 
nucleotide 427 for one nom1al allele (A) and one mutant allele (B). The 
normal allele had the same sequence as that published for human c-kit 
(Yarden e/ ai, 1987), and was confirmed in two other clones. The mutant 
allele had the same sequence as described except at codon 136, which was 
CGT instead of TGT, resulting in the substitution of arginine for cysteine. 
The sequence of tlus clone was confirmed in four other clones from twO 
independent PCR reactions. 
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A. Normal B. Mutant 
GATC GATC 
--
- -; =r 
--
=.....:C 
---
--
lys Arg Thr Tyr His 
Mutant 5'-AAA CGC ACC TAC CAT 
3'-TTT GCG IGG ATG GTA 
t Nonnal 5'-AAA CGC ,GCC TAC CAT 
3'-TTT GCG ,CGG ATG GTA 
lys Arg Ala Tyr His 
Figure 3. Partial nucle otide sequence analysis of c-kit exon-3 
cDNA from proband 3. Exon 3 from proband 3 (Fig 1, laue 4) was 
amplified by PCR and cloncd into M13. Shown are portions of the 
sequencing ladder spanni ng the mutation at nucleotide 553 for one normal 
alle le (A) and onc mutant allele (B). l30th sequcnccs arc the same as that 
published for human c-ki( (Yarden et nl, 1987) cxcept at codon "178, where 
ACC iJ) the mutant aUcle results in thc substitu tion of threonine for ala n ine. 
The sequence was con fi rmed in multiple other clones from two indepen-
dent PCR rcactions. 
Proband 4 Is Heterozygous for an Insertion in Exon 2 
SSCP analysis of the amplified DNA fragments corresponding to 
exon 2 demonstrated a variant SSCP pattern fo r proband 4 (not 
shown). To determine the basis fo r this variant, we independen tly 
reamplified and cloned the PCR product. Automated sequencing of 
11 clones demonstrated five clones with a four-base insertion and 
six clones with the normal seq uence (Fig 4). The inserted se-
I quence, TCCA, occurs at three tandemly repeated TCCA bases 
(nucleotides 133-144) in Kit exon 2 . T his frameshift mutation 
results in a 14-mnino acid nonsense peptide term inating at a novel 
in-frame TAG at codons 54 - 55. Beca use this insertion increases the 
size of a Mspl res triction digest fi'agment £i'om 30 to 34 bases, the 
presence of the heterozygous mutation was confirmed after diges-
tion of an independently ampLi flCd PCR product from proband 4 
and a normal contro l by electrophoresis on a 5% NuSieve agarose 
minigel (not shown) . 
DISCUSSION 
This article repons missense mutations in the extracell ular ligand-
binding domain of the Kit receptor that are associated with a 
piebald phenotype. T he loss of tbe highly conserved cysteine at 
codon 136 is almost certainly the cause of depigmentation in 
probands 1 and 2. Indeed, this cysteine is tho ught to participate in 
a critical disulfide bond required fo r formation of the D2 loop 
(Hanks et ai, 1988), a domain recently shown to be essential for 
ligand binding (Blechman et (/1, 1993a, 1993b; Lev e/ ai , 1993). 
Th us, the loss of the D2 loop appears li kely to impair ligand 
binding. Although these studies cannot rule out the alternate 
possibility that abnormal fo lding of the mutant protein prevents 
insertion into the cell m embrane, rep lacement of the homologous 
cysteines in the 19-Like loops of a rela ted tyros ine kinase, fi broblast 
growth factor receptor-1 , abolished ligand binding bu t did not 
affec t membrane insertion (Hou e/ (/1, 1992; Z immer el (/1, 1993). 
The pathologic significance of the codon-178 mutation is less 
certain. As expected for a region involved in the specificity of 
ligand binding, this res idue is not conserved in other members of 
the Kit fam il y, such as the receptors for macrophage colony-
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Figurc 4. Partial nucleotide sequcncc analysis of c-kit cxon-2 
cDNA from proband 4 . Sections of the sequencing chromatograms 
obtained by bidirectiona l dye terminator sequencing of one normal all ele 
(A) and one mutant all ele (B). Exon 2 was ampli fied by PCR and cloned by 
TA cloning into t he PCR II vector (Invitrogen). l30th sequences arc the 
same as th<lt published for human c-ki( (Yarden e( ai, 1987), except for a 
four-base TCCA insertion occurring at three tandemly rcpeated TCCA 
bases (nucleotides 133-144). T he mutant sequence was confi rmed in 
mul tiple other clones fro m two independent PCR reactions. 
stimulating fuctor and platelet-del"ived groWtll factor. On tlle other 
hand , the alanine at codon 178 is conserved in huma.n , mouse, and 
rat Kit. T he absence of this mu tation in 20 unrelated normal and 
piebald subjects or its detection in more than 50 other reported 
human samples screened by SSCP or complete DNA sequencing 
(Yarden e( (/1, 1987; Ezoe e/ (/1, 1995; Nakata et (/1, 1995) suggests 
that this is not a common po lym orphism. Presumably, a substitu tion 
close to the conserved cysteines at codons 183 and 186 could affect 
formation of either the D2 disulfide bond or a second potential 
disulfide bond between the cysteines at codons 183 and 151. T h e 
defect resulting fro m the substitution at codon 178 appears to be 
associated with a more subtl e defect than that resulting from loss of 
the cysteine at codon 136, however, as suggested by the unusually 
mild depigmentation observed in this proband . 
T he proximal fra meshift mutation in exon 2 adds a fourth TCCA 
tetranucleotide to the normal sequence of three tandemly repellted 
un.its, consistent with a slipped-strand mispairing mechanism (Coo-
per and Krawczak, 1991) . T he frameshift is predicted to result in 
the biosynthesis of a truncated and nonfunctional Kit polypeptide. 
Although it has been suggested, based on a previously reported 
frames hift mutation in exon 2, that haploinsufficiency is associated 
with a very m.i1d piebald phenotype (Spritz e/ ai, 1992b), proband 4 
displays extensive leukoderma with large areas of depigmentation 
on the llbdomen , anns, and legs. Presumably, differences ill genetic 
background may account in part for the phenotypic variabiljry 
observed in different human kindreds with Kit haploinsufficiency, 
similar to previous observations on the effect of Kit mutant alleles 
in different mouse inbred strains (Silvers, 1979) . 
Even after including the two novel missense mutations reported 
here, 14 of the 16 reported mouse and human Kit missense 
mutations that resul t in depigmentation map to tll e in trace llular 
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domains that encode kinase actlvlty. The low trequency of muta-
tions in the c-kit extracellular domain implies that most am ino acid 
substitutions in this region cause too mild a defect to result in 
depigmentation. One explan ation for this finding is suggested by 
recent experiments indicating that monovalent binding of li gand is 
sufficient to induce Kit receptor dimerizatioll . On the other hand, 
both chains of the resulting dimer must have kinase activity to 
catalyze subsequent autopbosphorylation (Lev ct ai, 1992). Th us, 
up to 75'Y., of the potential dimers aflected by kinase domain 
mutations, i.e., homod imers of the mutant and heterodimers of the 
mutant and normal gene products, would be defective, resulting in 
a "dominant negative" effect on receptor function (Tan et ai, 1990; 
Fleischman, 1992). In contrast, only 25% of the potential dimers 
affected by a ligand-binding mutation, i.e., homodimers of the 
mutant gen e product, would be impaired for ligand-mediated 
climerization, presumably too mild a defect to affect pigmentation. 
If the c ited model is correct, disruptio11 of the D2 Ig- like loop by 
mutations at or near the critical cysteine residues may be unu sual in 
its ability to exert a dominant n egative action o n receptor het-
erodimers . [n accord with this suggestion, the mutations that cause 
the Crouzon, Jackson-Weiss, and Pfeiffer fo rms of cran iosynostosis 
Oabs et ai , 1994; Reardon et ai, 1994; Oldridge ef ai, 1995; Rutland 
et ai, 1995; Schell ct ai, 1995; Steinberger ef ai, 1995) are similarly 
clustered at or near the conserved cystein es req uired for formation 
of one Ig-like .loop in the fibroblast growth factor receptors 1 and 
2. On the other hand, at least for Kit, the mild piebaldi sm observed 
in the three kindreds reported here with missense mutations in exon 
3 suggests that the receptor defect associated with loss of the D2 
loop is still less severe than that resulting from some null or deletion 
mutation s and from the majority of kinase mutations. 
T his st"dy "'liS SHpp"rted i" plln I!y II 1/ A Mait Award fIIlfl A"/"rica,, CIIIIC'''' 
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